compositions comprising an inverse agonist of the gabaa receptors and a partial agonist nicotine, a selective modulator of oestrogene, receiving a smidgen of estrogen and vitamin e

摘要

the invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an agent. the first is an inverse agonist of the gabaa and the second agent is a partial agonist nicotine receptors, an agent oestrogenique, a selective modulator of a smidgen of estrogen receptors or vitamin e.application: the use of this composition for the simulation of the cognition and treatment of diseases of cognitive dysfunction.